The bands on a vitamin D report come from expert judgements, not a population range, and SACN, NHS laboratories, the US Institute of Medicine and the Endocrine Society draw them differently. What moves the result and when testing helps.
A vitamin D result of 40 nmol/L is "may be inadequate in some people" at one NHS laboratory and "insufficiency" at another. It is below the 50 nmol/L that a US expert committee said covers the needs of nearly everyone, and since 2024 the Endocrine Society no longer endorses specific 25(OH)D levels to define deficiency or sufficiency. The number is the same; the label depends on whose scale you hold it against.
This material is for information only. It is not a diagnosis and does not replace a consultation with a doctor.
What does the vitamin D test actually measure?
The test measures 25-hydroxyvitamin D, written 25(OH)D or 25-OH D. The UK Scientific Advisory Committee on Nutrition (SACN, 2016) describes it as an indicator of exposure to vitamin D, from the skin and from the diet. Gloucestershire Hospitals, an NHS laboratory, measures it by immunoassay and reports total 25-hydroxyvitamin D.
Two units are in use: UK laboratories report nmol/L, while ng/mL is common elsewhere. The US Institute of Medicine committee (2011) gives both: 20 ng/mL is 50 nmol/L, 30 ng/mL is 75 nmol/L, and 50 ng/mL is 125 nmol/L. Check the unit before comparing a result with any number on this page.
Where do the bands on your report come from?
Not from a population range, as with most blood tests, but from expert judgements, most of them about bone health, and they do not all agree.
SACN (2016). The risk of poor musculoskeletal health rises below 25 nmol/L, so SACN calls 25 nmol/L a "population protective level": the concentration everyone in the UK should stay above throughout the year. In discussing rickets, SACN adds that it is not a clinical threshold for diagnosing the disease.
Two NHS laboratories. Gloucestershire, following the National Osteoporosis Society guideline of 2018, calls below 25 nmol/L deficient, 25–50 "may be inadequate in some people", and above 50 "sufficient for almost the whole population". Severn Pathology in Bristol uses the same cut-offs but other words: severe deficiency, insufficiency and adequate.
US Institute of Medicine (2011). A level of at least 50 nmol/L (20 ng/mL) meets the needs of at least 97.5% of the population, and 40 nmol/L (16 ng/mL) of about half. Levels above 75 nmol/L (30 ng/mL) were not consistently linked with more benefit.
Endocrine Society (2024). Its guideline found no clear evidence defining the optimal 25(OH)D level for preventing disease, no longer endorses its earlier target of 75 nmol/L (30 ng/mL), and no longer endorses specific levels for sufficiency, insufficiency or deficiency.
That is the spread from the opening: 40 nmol/L sits in the middle band in the UK and below the US figure for nearly everyone, while the 2024 guideline gives it no label.
Why can vitamin D be low?
Season. Gloucestershire notes that levels are higher at the end of summer and lower in winter, following changes in UVB exposure. A result in February and one in September are not directly comparable.
Less from skin or diet. Since 25(OH)D reflects exposure from both, little time in the sun and little vitamin D in food both show up in it.
Why can vitamin D be high?
A genuinely high level. The Institute of Medicine committee says levels above 125 nmol/L (50 ng/mL) should raise concern about possible adverse effects, and that risks have been identified for some outcomes above that level.
The measurement itself. Gloucestershire warns that very high protein levels in the blood can give falsely high results, and asks people taking high-dose biotin to have blood taken at least 8 hours after the last dose.
When is the test used, and when is it repeated?
Testing everyone is not the default. The Endocrine Society (2024) suggests against routine 25(OH)D testing in the general populations it considered, healthy adults of all ages and pregnancy among them. Gloucestershire says routine screening is not recommended in people without symptoms and lists the reasons it is done: bone diseases that may improve with vitamin D, before some bone treatments, and musculoskeletal symptoms.
Repeating too soon adds little. Gloucestershire has a minimum retesting interval of 3 months; Severn Pathology does not analyse a sample within 6 months of a previous result.
What does this number not mean?
One vitamin D result is not a diagnosis. A low value is not by itself a diagnosis of bone disease, and SACN says its threshold is not a diagnostic one.
A value in the middle band means different things on different scales, and a winter result may be lower than the same person's summer one.
It is not a reason to start, stop or change any medicine or supplement, including vitamin D, on your own.
What to do with the number
Bring the result to your doctor with its unit, the bands printed on your report and the month the blood was taken. Mention bone or muscle symptoms, fractures, conditions affecting the gut, liver or kidneys, pregnancy, and any vitamin D or other supplements you take and in what amount. Keep earlier results with their dates. You can follow vitamin D over time in your Lonevi health map. Our article on vitamin D and longevity covers what correcting a deficiency can and cannot do, and the one on vitamin D after sixty summarises the trials in older adults.
Sources
Scientific Advisory Committee on Nutrition. Vitamin D and Health. 2016. gov.uk
Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–58. PMID 21118827
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109:1907–1947. PMID 38828931
Gloucestershire Hospitals Pathology. 25-hydroxyvitamin D. 2026. gloshospitals.nhs.uk
North Bristol NHS Trust, Severn Pathology. Vitamin D: test information. nbt.nhs.uk
Articles in this section are educational and are not medical advice, a diagnosis, or a prescription. Consult a qualified professional before acting on anything you read here.
Read next
ExplainerBiomarkersCreatinine and eGFR: why one low result is checked again
eGFR is calculated from creatinine, age and sex, and this page uses the race-free CKD-EPI 2021 equation. Where the KDIGO categories come from, what can shift creatinine, and why chronic kidney disease needs a change lasting more than 3 months.
ExplainerBiomarkersLDL cholesterol test: a number read against your risk, not a range
Most laboratories calculate LDL rather than measure it, and some print no range at all. How NICE and European goals differ by risk, what usually raises LDL, and what a doctor checks before deciding anything.
ExplainerBiomarkersCRP blood test: one protein, two scales that read it differently
Routine CRP looks for infection and inflammation, high-sensitivity CRP for heart risk, and their cut-offs differ. How fast CRP rises and falls, what raises the baseline, and what doctors do with a single high value.
